Brief: Schnell Biopharmaceuticals to change co name to Aprogen Pharmaceuticals
07/04/2017 10:26
April 7 (Reuters) - Schnell Biopharmaceuticals Inc
003060.KS :
* Says it will change co name to Aprogen Pharmaceuticals Inc
* Says effective date is April 12
Source text in Korean: https://goo.gl/xAhmys
Further company coverage: 003060.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on Aprogen Biologics
See all newsBrief: Aprogen Biologics To Conduct Capital Increase Of 117 Billion Won For Operational Funds
Brief: Aprogen Pharmaceuticals To Lend 125 Billion Won To Affiliate Aprogen Biologics To Secure Biosimilar Production Facilities
Medics and volunteers try to prop up Ukraine's health system
Brief: Aprogen Kic To Acquire Shares Worth $17 Mln In Its Unit
Brief: Aprogen sells 7.69 pct stake in Aprogen pharmaceuticals